Literature DB >> 18237264

West Nile virus neuroinvasive disease incidence in the United States, 2002-2006.

Nicole P Lindsey1, Stephanie Kuhn, Grant L Campbell, Edward B Hayes.   

Abstract

As the geographic range of reported human West Nile virus (WNV) disease has expanded across the United States, seasonal transmission and outbreaks have persisted over several years in many areas of the country. West Nile virus neuroinvasive disease (WNND) case reports from 2002 to 2006 were reviewed to determine which areas of the country have the highest reported cumulative incidence and whether those areas have had consistently high annual incidence. During the 5-year period examined, 9632 cases of WNND were reported nationwide. The cumulative incidence of WNND ranged from 0.2 to 32.2 per 100,000 population by state and from 0.1 to 241.2 per 100,000 population by county. States and counties with the highest cumulative incidence were primarily located in the northern Great Plains. States with consistently high annual incidence included South Dakota, North Dakota, Wyoming, New Mexico, Mississippi, Nebraska, Louisiana, and Colorado. All of these states, with the exception of New Mexico, were also among the states with the highest cumulative incidence. Counties with repeatedly high annual incidence were also primarily in the Great Plains and mid-South. The risk of WNND appears to be highest in areas where the primary WNV vectors are Culex tarsalis and Cx. quinquefasciatus mosquitoes.

Entities:  

Mesh:

Year:  2008        PMID: 18237264     DOI: 10.1089/vbz.2007.0137

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  25 in total

1.  Epidemiology of West Nile virus in the highly epidemic state of North Dakota, 2002-2007.

Authors:  Stephanie M Borchardt; Michelle A Feist; Tracy Miller; Tze Shien Lo
Journal:  Public Health Rep       Date:  2010 Mar-Apr       Impact factor: 2.792

2.  Population genetic data suggest a role for mosquito-mediated dispersal of West Nile virus across the western United States.

Authors:  Meera Venkatesan; Jason L Rasgon
Journal:  Mol Ecol       Date:  2010-03-08       Impact factor: 6.185

3.  Weather and land cover influences on mosquito populations in Sioux Falls, South Dakota.

Authors:  Ting-Wu Chuang; Michael B Hildreth; Denise L Vanroekel; Michael C Wimberly
Journal:  J Med Entomol       Date:  2011-05       Impact factor: 2.278

Review 4.  Neuroinvasive arboviral disease in the United States: 2003 to 2012.

Authors:  James T Gaensbauer; Nicole P Lindsey; Kevin Messacar; J Erin Staples; Marc Fischer
Journal:  Pediatrics       Date:  2014-08-11       Impact factor: 7.124

5.  A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Δ30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers.

Authors:  Kristen K Pierce; Stephen S Whitehead; Beth D Kirkpatrick; Palmtama L Grier; Adrienne Jarvis; Heather Kenney; Marya P Carmolli; Cynthia Reynolds; Cecilia M Tibery; Janece Lovchik; Anna Janiak; Catherine J Luke; Anna P Durbin; Alexander G Pletnev
Journal:  J Infect Dis       Date:  2016-10-25       Impact factor: 5.226

6.  Transcellular transport of West Nile virus-like particles across human endothelial cells depends on residues 156 and 159 of envelope protein.

Authors:  Rie Hasebe; Tadaki Suzuki; Yoshinori Makino; Manabu Igarashi; Satoko Yamanouchi; Akihiko Maeda; Motohiro Horiuchi; Hirofumi Sawa; Takashi Kimura
Journal:  BMC Microbiol       Date:  2010-06-08       Impact factor: 3.605

7.  Geographic variability in geocoding success for West Nile virus cases in South Dakota.

Authors:  Christine L Wey; Jennifer Griesse; Lon Kightlinger; Michael C Wimberly
Journal:  Health Place       Date:  2009-06-12       Impact factor: 4.078

8.  The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers.

Authors:  Anna P Durbin; Peter F Wright; Amber Cox; Wangeci Kagucia; Daniel Elwood; Susan Henderson; Kimberli Wanionek; Jim Speicher; Stephen S Whitehead; Alexander G Pletnev
Journal:  Vaccine       Date:  2013-08-19       Impact factor: 3.641

9.  Complete genome analysis and virulence characteristics of the Louisiana West Nile virus strain LSU-AR01.

Authors:  Arun V Iyer; Marc J Boudreaux; Nobuko Wakamatsu; Alma F Roy; Abolghasem Baghian; Vladimir N Chouljenko; Konstantin G Kousoulas
Journal:  Virus Genes       Date:  2009-01-08       Impact factor: 2.332

10.  The incidence risk, clustering, and clinical presentation of La Crosse virus infections in the eastern United States, 2003-2007.

Authors:  Andrew D Haddow; Agricola Odoi
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.